CME Group Inc. Website

CME Group Inc.

NasdaqGS-CME

Basic

  • Market Cap

    $70.98B

  • EV

    $73.29B

  • Shares Out

    360.07M

  • Revenue

    $5,615.5M

  • Employees

    3,565

Margins

  • Gross

    100%

  • EBITDA

    68.62%

  • Operating

    62.4%

  • Pre-Tax

    73.19%

  • Net

    56.94%

  • FCF

    59.89%

Returns (5Yr Avg)

  • ROA

    1.93%

  • ROTA

    45.55%

  • ROE

    9.34%

  • ROCE

    7.76%

  • ROIC

    1.76%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $225.93

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,557.9M

  • Net Debt

    $2,314.4M

  • Debt/Equity

    0.14

  • EBIT/Interest

    21.98

Growth (CAGR)

  • Rev 3Yr

    6.86%

  • Rev 5Yr

    5.11%

  • Rev 10Yr

    6.51%

  • Dil EPS 3Yr

    18.1%

  • Dil EPS 5Yr

    10.43%

  • Dil EPS 10Yr

    11.34%

  • Rev Fwd 2Yr

    4.76%

  • EBITDA Fwd 2Yr

    6.15%

  • EPS Fwd 2Yr

    3.36%

  • EPS LT Growth Est

    3.89%

Dividends

  • Yield

  • Payout

    50.61%

  • DPS

    $4.45

  • DPS Growth 3Yr

    8.85%

  • DPS Growth 5Yr

    9.32%

  • DPS Growth 10Yr

    9.35%

  • DPS Growth Fwd 2Yr

    2.2%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Operating Revenues

4,464.6

4,442.8

4,342

4,753.6

5,252.2

5,270.5

Other Revenues, Total

403.4

440.8

347.7

255.2

316.9

345

Total Revenues

4,868

4,883.6

4,689.7

5,008.8

5,569.1

5,615.5

Total Revenues % Chg.

13%

0.3%

-4%

6.8%

11.2%

10%

Gross Profit

4,868

4,883.6

4,689.7

5,008.8

5,569.1

5,615.5

Selling General & Admin Expenses, Total

1,446.5

1,491.2

1,418.2

1,456.4

1,570

1,576.6

Depreciation & Amortization

158.6

153.2

147.8

134.9

126

124.2

Amortization of Goodwill and Intangible Assets

314.7

311.2

237.6

227.7

226.6

225

Other Operating Expenses

292.1

254.6

281.6

187.1

188.2

185.5

Other Operating Expenses, Total

2,211.9

2,210.2

2,085.2

2,006.1

2,110.8

2,111.3

Operating Income

2,656.1

2,673.4

2,604.5

3,002.7

3,458.3

3,504.2

Interest Expense, Total

-178

-166.2

-166.9

-162.7

-159.4

-159.4

Interest And Investment Income

637.9

182.7

306.9

2,198.4

5,275.3

4,988.9

Net Interest Expenses

459.9

16.5

140

2,035.7

5,115.9

4,829.5

Income (Loss) On Equity Invest.

176.8

190.6

245.8

301.1

296.9

305.9

Currency Exchange Gains (Loss)

-7.2

-9.7

40.7

13.2

-22.6

-22.6

Other Non Operating Income (Expenses)

-534.9

-122.4

-58.1

-1,862.4

-4,694.9

-4,506.9

EBT, Excl. Unusual Items

2,750.7

2,748.4

2,972.9

3,490.3

4,153.6

4,110.1

Merger & Related Restructuring Charges

Gain (Loss) On Sale Of Assets

-61.1

-26.3

400.7

Other Unusual Items

EBT, Incl. Unusual Items

2,689.6

2,722.1

3,373.6

3,490.3

4,153.6

4,110.1

Income Tax Expense

573.8

615.7

736.7

799.3

927.4

912.5

Earnings From Continuing Operations

2,115.8

2,106.4

2,636.9

2,691

3,226.2

3,197.6

Minority Interest

0.7

-1.2

-0.5

Net Income

2,116.5

2,105.2

2,636.4

2,691

3,226.2

3,197.6

Preferred Dividend and Other Adjustments

19.3

33.8

40.6

40.3

Net Income to Common Incl Extra Items

2,116.5

2,105.2

2,617.1

2,657.2

3,185.6

3,157.3

Net Income to Common Excl. Extra Items

2,116.5

2,105.2

2,617.1

2,657.2

3,185.6

3,157.3

Total Shares Outstanding

357.5

358.1

358.6

358.9

359.2

359.3

Weighted Avg. Shares Outstanding

357.2

357.8

358.3

358.7

359

359.1

Weighted Avg. Shares Outstanding Dil

358.2

358.5

358.9

359.2

359.5

359.6

EPS

5.9

5.9

7.3

7.4

8.9

8.8

EPS Diluted

5.9

5.9

7.3

7.4

8.9

8.8

EBITDA

3,129.4

3,137.8

2,989.9

3,365.3

3,810.9

3,853.4

Effective Tax Rate

21.3%

22.6%

21.8%

22.9%

22.3%

22.2%